Atrial fibrillation in hypertension: predictors and outcome.
about
Atrial Fibrillation: The Science behind Its DefianceAtrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy.Disturbed Left Atrial Function is Associated with Paroxysmal Atrial Fibrillation in Hypertension.Cardiovascular magnetic resonance in systemic hypertensionEffect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.End organ damage in hypertension.A functional single-nucleotide polymorphism in interleukin-6 promoter is associated with p wave dispersion in hypertensive subjects with atrial fibrillation.The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke.Hospitalizations from Hypertensive Diseases, Diabetes, and Arrhythmia in Relation to Low and High Temperatures: Population-Based StudyTargeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertensionSitagliptin Modulates the Electrical and Mechanical Characteristics of Pulmonary Vein and Atrium.P-wave dispersion: What we know till now?Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention.The impact of height on the risk of atrial fibrillation: the Cardiovascular Health StudyHypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications.Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertensionAngiotensin II receptor blockers in the prevention of complications from atrial fibrillationMetabolic syndrome and cardiometabolic risk: an update.Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies.Association of left atrial enlargement with ventricular remodeling in hypertensive Chinese elderly.Electrocardiographic left ventricular hypertrophy predicts atrial fibrillation independent of left ventricular mass.Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.Atrial Dilatation Development in Hypertensive Treated Patients: The Campania-Salute Network.The effects of rate and rhythm control on blood pressure and antihypertensive drug usage in patients with atrial fibrillation and hypertension enrolled in the AFFIRM trial.Augmentation of pulmonary vein backflow velocity during left atrial contraction: a novel phenomenon responsible for progression of atrial fibrillation in hypertensive patients.Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes.Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.Diabetes and new-onset atrial fibrillation in a hypertensive population.Proteinuria Detected by Urine Dipstick Test as a Risk Factor for Atrial Fibrillation: A Nationwide Population-Based Study.Atrial extrasystoles after exercise predict atrial fibrillation in patients with left ventricular hypertrophy.
P2860
Q28072139-C7F69438-83F5-49B1-B00D-8ACC58B3FE3DQ30234626-BC2BC5B0-75C9-46D4-8BB8-AAA4ADD504E6Q30375302-FC9D03F6-EAFF-44BB-930E-82B4A4D915D7Q30414713-06C739B6-A0B4-4037-970C-92D975406F2AQ30438722-05B2BDBA-3150-4A56-9ABF-0099D17A440CQ30466693-D2309287-4E25-4D20-BB18-6CA107E39FB8Q30772422-35F90891-93C8-4F49-8DAB-624B6FA1230DQ33625043-D3433716-8612-4C82-A35B-13278E625B3CQ34018990-28C905C2-4E13-4E4B-B05F-9CE95130692CQ34444944-BA39089E-3A6C-47BD-BD83-6D73DABABA61Q34770061-B5A67463-1A01-41A1-9870-1CBB3CE7B374Q34915626-C4DCD512-6D3F-4980-BF7E-E28F614230EBQ35609742-B1A50E2B-E415-4F18-9F53-8DF574DE0465Q35632061-6DC71A5D-4767-4800-B574-3EFE567D2A54Q36085137-3BBD43C9-A5BF-4251-94A9-2CADA9C25274Q36302833-D5B085A2-D3B8-437D-A7AF-D6EA61A9101EQ36383125-212D4457-810F-46EE-82D2-69050FF27E32Q36721264-D0DCC192-D7D9-45E4-9C03-B72ECF52E70FQ36748471-55E8C523-1D67-46FB-86D1-9AD3B0037E6CQ36766941-ECFEA2AB-10B0-46A5-8B07-500C612832EDQ36926238-BB4D6750-2775-4462-9136-71F6AFC42E0CQ37109220-3E226EC3-2511-474E-957D-179075032879Q37120926-B12D2799-A245-417F-BC2A-EAEFC758909EQ37168763-73D9D15D-6BA9-42FA-8D4B-BB0AC4C31F07Q37266655-2BD4FDCA-8B2F-4FC3-9AD8-1B6766584F66Q37354665-7AF982A9-87B9-43F6-9172-A730894A4334Q37370043-3DADDE88-0927-466C-92AD-FF4541645B74Q37495894-857E2B4E-D457-4DB4-9655-686F26779B4FQ38079711-88176070-6E62-4AD9-9A8F-110442F0033BQ38936247-A39EBCF8-761C-4F5F-B70A-4DD5F273CC35Q39064464-B516D541-82A5-4B41-88ED-2C384FCEEE91Q39164366-BD64DEAB-3CE4-4972-BE6D-3E27C187CACBQ39773724-9696668E-4923-486D-A89D-D71C328E6AF1Q39874911-45F4F890-1264-4177-9CD8-3E6BD5231A0DQ40194997-221F008F-A14D-47E6-8D66-4101F4C32B71Q40275970-ACB30B5C-EFD9-4840-8125-A41D56BD56B8Q40296244-AC66EAB7-8220-4786-8069-6109BEA125DBQ40873653-A25647E7-C6A8-4D06-BD14-33EAC884D405Q41108699-26005420-6241-401D-83A5-5C8495471E98Q42832238-69E0F523-3CE5-4E5A-8844-49F07A0AE905
P2860
Atrial fibrillation in hypertension: predictors and outcome.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Atrial fibrillation in hypertension: predictors and outcome.
@en
type
label
Atrial fibrillation in hypertension: predictors and outcome.
@en
prefLabel
Atrial fibrillation in hypertension: predictors and outcome.
@en
P2093
P1433
P1476
Atrial fibrillation in hypertension: predictors and outcome.
@en
P2093
Carlo Porcellati
Claudia Borgioni
Erberto Carluccio
Fabio Angeli
GianPaolo Reboldi
Maria Grazia Sardone
Maurizio Bentivoglio
Paolo Verdecchia
Roberto Gattobigio
P304
P356
10.1161/01.HYP.0000052830.02773.E4
P407
P577
2003-02-01T00:00:00Z